Sitagliptin Phosphate/Metformin Hydrochloride

磷酸西格列汀/盐酸二甲双胍

Report date: 2025/02/19 11:17:06

Base Information

Drug NameSitagliptin Phosphate/Metformin Hydrochloride
Drug Alias NameMetformin Hydrochloride/Sitagliptin Phosphate西格列汀二甲双胍VelmetiaJanumet捷诺达
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDipeptidyl peptidase IV inhibitorsProtein kinase AMP-activated non-catalytic subunit beta 1 activators
TargetsDipeptidyl peptidase IVProtein kinase AMP-activated non-catalytic subunit beta 1
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsDiabetes Mellitus, Type 2
Approved Indications in ChinaDiabetes Mellitus, Type 2
Original Approved Country/TerritoryUnited States
Original Approved Date2007/03/30
Country/TerritoryUnited StatesEgyptEU +[4] 
CombinationsYes
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesGenuine Research Center, EgyptBio-innova Co LtdMerck Sharp & Dohme Bv +[5] 
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeA10BD07
Related LinksN/A